SEC Form 4 · accession 0001171843-17-007021
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Arthur Eldridge
Officer — Sr VP, CFO, Treasr, Asst Secy
Period of report
Nov 14, 2017
Accepted (ET)
Nov 14, 2017 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 14, 2017 | P | 295 | $1.69 | A | 1,545 | I | As custodian for child's UTMA account |
| Common Stock | holding | — | — | — | 12,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.